Cara Therapeutics Statistics

Total Valuation

CARA has a market cap or net worth of $23.18 million. The enterprise value is $25.15 million.

Market Cap	23.18M
Enterprise Value	25.15M

Important Dates

The last earnings date was Thursday, November 14, 2024, after market close.

Earnings Date	Nov 14, 2024
Ex-Dividend Date	n/a

Share Statistics

CARA has 54.86 million shares outstanding. The number of shares has increased by 1.28% in one year.

Current Share Class	54.86M
Shares Outstanding	54.86M
Shares Change (YoY)	+1.28%
Shares Change (QoQ)	+0.22%
Owned by Insiders (%)	1.22%
Owned by Institutions (%)	26.57%
Float	46.79M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.66
Forward PS	4.94
PB Ratio	32.79
P/TBV Ratio	32.79
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	2.90
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.77, with a Debt / Equity ratio of 62.23.

Current Ratio	4.77
Quick Ratio	4.32
Debt / Equity	62.23
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-12.76

Financial Efficiency

Return on equity (ROE) is -221.25% and return on invested capital (ROIC) is -74.81%.

Return on Equity (ROE)	-221.25%
Return on Assets (ROA)	-61.79%
Return on Capital (ROIC)	-74.81%
Revenue Per Employee	$157,927
Profits Per Employee	-$1.74M
Employee Count	55
Asset Turnover	0.10
Inventory Turnover	57.11

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -31.96% in the last 52 weeks. The beta is 0.68, so CARA's price volatility has been lower than the market average.

Beta (5Y)	0.68
52-Week Price Change	-31.96%
50-Day Moving Average	0.29
200-Day Moving Average	0.46
Relative Strength Index (RSI)	75.89
Average Volume (20 Days)	3,246,754

Short Selling Information

The latest short interest is 576,662, so 1.05% of the outstanding shares have been sold short.

Short Interest	576,662
Short Previous Month	1.26M
Short % of Shares Out	1.05%
Short % of Float	1.23%
Short Ratio (days to cover)	2.20

Income Statement

In the last 12 months, CARA had revenue of $8.69 million and -$95.53 million in losses. Loss per share was -$1.75.

Revenue	8.69M
Gross Profit	-102.42M
Operating Income	-82.39M
Pretax Income	-122.54M
Net Income	-95.53M
EBITDA	-82.11M
EBIT	-82.39M
Loss Per Share	-$1.75

Full Income Statement

Balance Sheet

The company has $42.04 million in cash and $44.00 million in debt, giving a net cash position of -$1.96 million or -$0.04 per share.

Cash & Cash Equivalents	42.04M
Total Debt	44.00M
Net Cash	-1.96M
Net Cash Per Share	-$0.04
Equity (Book Value)	707,000
Book Value Per Share	0.01
Working Capital	37.87M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$74.24 million and capital expenditures -$3.10 million, giving a free cash flow of -$77.34 million.

Operating Cash Flow	-74.24M
Capital Expenditures	-3.10M
Free Cash Flow	-77.34M
FCF Per Share	-$1.41

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-948.50%
Pretax Margin	-1,099.76%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CARA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.28%
Shareholder Yield	-1.28%
Earnings Yield	-412.07%
FCF Yield	-333.63%

Analyst Forecast

The average price target for CARA is $1.00, which is 136.63% higher than the current price. The consensus rating is "Hold".

Price Target	$1.00
Price Target Difference	136.63%
Analyst Consensus	Hold
Analyst Count	3
Revenue Growth Forecast (5Y)	21.03%
EPS Growth Forecast (5Y)	-25.74%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

CARA has an Altman Z-Score of -24.18 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-24.18
Piotroski F-Score	2